TRENDS IN MEDICATION PRESCRIBING FOR ACNE IN THE UNITED STATES ACCORDING TO PATIENT AGE

Author(s)

Adam A Uhas, BS, Doctoral Student1, Rajesh Balkrishnan, PhD, Merrell Dow Professor2, Steven R Feldman, MD, PhD, Professor31The Ohio State University College of Pharmacy, Columbus, OH, USA; 2 The Ohio State University, Columbus, OH, USA; 3 Wake Forest University School of Medicine, Winston Salem, NC, USA

Objective: The purpose of this descriptive study was to examine the most common treatment classes based on drug class and the describe the differences in prescribing methods across age groups. Methods: Information was collected from the PharMetrics Integrated Patient-centric Database, a large collection of administrative claims. At the time of this analysis in 2004, there were more than 80 public and private healthcare plans included in the database, representing approximately 9.6 million unique patients. Analysis was performed using the Total Resource Utilization (TRU) Benchmarks process, a descriptive methodology organizes and separates information, from a third-party database, into accessible benchmarks for comparison. These results were then factored against age groups. The age group break down is as follows: 12-14, 15-17, 18-24, and 24-35. Results: The most commonly prescribed medications in the United States for acne were: New generation retinoid products, benzoyl peroxide-based combo products , topical corticosteroids by Rx only, Topical antibiotics, common topical retinoid products, oral anti-biotics, as well as antidepressants and benzodiazepines in some age categories. The age breakdown was as follows: Ages 12-14: Oral antibiotics (38.8%), Benzoyl peroxide-based products (32.7%), New generation retinoid products (30.1%), Topical antibiotics (21.7%), Common topical retinoid products (20.7%) Ages 15-17: Oral antibiotics (55.0%) Benzoyl peroxide-based products (32.0%) New generation retinoid products (31.3%) Topical antibiotics (21.3%), Common topical retinoid products (21.1%) Ages 18-24: Oral antibiotics (52.6%), New generation retinoid products (28.3%), Benzoyl peroxide-based products (26.8%), Oral contraceptives (24.8%), Topical antibiotics (20.4%) Ages 25-35: Oral antibiotics (44.2%), Oral contraceptives (33.0%), Topical antibiotics (22.1%), Benzoyl peroxide-based products (21.5%), New generation retinoid products (20.1%). Conclusion: It was determined that significant differences by medication type do in fact occur in all the different age groups. The discrepancies can be clearly observed and on physician to physician bases, one can determine if their own particular prescribing method is appropriate.

Conference/Value in Health Info

2008-05, ISPOR 2008, Toronto, Ontario, Canada

Value in Health, Vol. 11, No. 3 (May/June 2008)

Code

PSS50

Topic

Health Service Delivery & Process of Care, Specialized Treatment Areas, Study Approaches

Topic Subcategory

Personalized & Precision Medicine, Post Marketing Studies, Prescribing Behavior

Disease

Sensory System Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×